Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 151 to 165 of 244 results for obesity

  1. Oxygen therapy for OSAHS: What is the clinical and cost effectiveness of nocturnal oxygen compared with placebo in people with OSAHS who are unable to tolerate CPAP?

    Comes from guidance Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s Number NG202 Date

    Research recommendation
    Published
    30 September 2021

  2. Upper airway surgery in people unable to tolerate or adhere to CPAP: What is the clinical and cost effectiveness of upper airway surgical interventions for people with OSAHS who are unable to tolerate or adhere to CPAP?

    Comes from guidance Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s Number NG202 Date

    Research recommendation
    Published
    30 September 2021

  3. What is the clinical and cost effectiveness of auto- and fixed-level continuous positive airway pressure (CPAP) for managing moderate and severe OSAHS?

    Comes from guidance Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s Number NG202 Date

    Research recommendation
    Published
    30 September 2021

  4. Treatment for people with COPD–OSAHS overlap syndrome: What is the optimal treatment for people with COPD–OSAHS overlap syndrome: non-invasive ventilation or CPAP?

    Comes from guidance Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s Number NG202 Date

    Research recommendation
    Published
    30 September 2021

  5. Auto- versus fixed-level CPAP for OSAHS: What is the clinical and cost effectiveness of auto- and fixed-level continuous positive airway pressure (CPAP) for managing mild obstructive sleep apnoea/hypopnoea syndrome (OSAHS)?

    Comes from guidance Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s Number NG202 Date

    Research recommendation
    Published
    30 September 2021

  6. Further research on robot-assisted kidney transplant should include studies comparing robot-assisted kidney transplant with open surgery. This should collect data on patient selection, warm ischaemia times, the need for conversion to open surgery, graft function, and long-term graft and patient survival.

    kidney transplant is limited in quantity and quality. For patients with obesity who would not otherwise be able to have a kidney...

    Research recommendation
    Published
    21 November 2018

  7. Probiotic and prebiotic supplements:- What is the clinical and cost effectiveness of probiotics or prebiotics to treat NAFLD in adults, young people and children?

    suggests associations between unfavourable disturbance in gut microbiota and obesity or type 2 diabetes, but there is very limited...

    Research recommendation
    Published
    24 August 2016

  8. Recommendation 3 Barriers and facilitators. Who should take action? Research councils, commissioners and funders. Researchers and investigators.

    obese children and young people and their families (including beliefs about obesity). Include: - ethnicity and cultural aspects -...

    Research recommendation
    Published
    9 June 2015

  9. When should testing for gestational diabetes take place – in the first or second trimester?

    for women diagnosed with gestational diabetes. However, maternal age and obesity are increasing, and some women (especially those from...

    Research recommendation
    Published
    9 June 2015

  10. Long‑term consequences of planning birth in different settings: What are the long‑term consequences for women and babies of planning birth in different settings?

    Secondary outcomes are impact on attachment between mother and child, obesity in children, autoimmune disease, chronic illness,...

    Research recommendation
    Published
    6 January 2023

  11. More research is needed on the following key outcomes:

    it is hard to get high-quality images, for example, scoliosis and morbid obesity whether the software works in groups that could...

    Research recommendation
    Published
    11 January 2024

  12. What is the effectiveness of awake body positioning in improving outcomes for people in hospital with COVID-19 who are not intubated and have higher oxygen needs?

    heart disease, chronic kidney disease, cancer, cerebral vascular disease, obesity) Source guidance details Comes from guidance COVID-19

    Research recommendation
    Published
    9 March 2022

  13. Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma (TA666)

    Evidence-based recommendations on atezolizumab (Tecentriq) with bevacizumab (Avastin) for treating advanced or unresectable hepatocellular carcinoma in adults who have not had previous systemic treatment.

    Technology appraisal guidance
    Published
    16 December 2020
    View recommendations

    Sections for TA666

  14. Liver disease (QS152)

    This quality standard covers identifying, assessing and managing chronic liver disease in children, young people and adults, and cirrhosis in young people and adults. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    29 June 2017
    View quality statements

    Sections for QS152

  15. The PolySoft hernia patch used with the ONSTEP technique to treat inguinal hernias (MIB9)

    NICE has developed a Medtech Innovation Briefing (MIB) on the Polysoft hernia patch for use with the ONSTEP technique to treat inguinal hernias

    Medtech innovation briefing
    Published
    26 August 2014